Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

NCT00236002 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

182

Enrollment

OTHER

Sponsor class

Stopped Slow accrual than anticipated.

Conditions

Osteoporosis

Interventions

DRUG: Alendronate

Sponsor

Canadian Urology Research Consortium

Collaborators

[object Object]
[object Object]